Total votes
1,307
all sessions
Attendance
100%
of floor votes
Near the chamber average
With party
81%
of cast votes
Near the chamber average
Bipartisan score
10%
crosses aisle rarely
Near the chamber average
Sponsored
10
bills & resolutions
Among the lowest in the chamber
Committees
3
assignments
1,307 roll-call votes
Voting record
Yea
490
voted in favor
Nay
817
voted against
Absent
0
missed votes
Total cast
1,307
across all sessions
Crossed party
240
votes against own party
This page
1,307
matching current filters
Bill
Description
Vote
Result
Tally
Date
SB 2693
Relating to the role of advocacy and support groups in the juvenile justice system.
Nay
Passed
21–10
Apr 30, 2025
SB 2844
Relating to the regulation of deer breeding; creating criminal offenses.
Yea
Passed
28–3
Apr 30, 2025
SB 1026
Relating to the authority of the attorney general to prosecute criminal offenses prescribed by the election laws of this state.
Nay
Passed
19–12
Apr 30, 2025
SB 584
Relating to the responsibility of consumer reporting agencies to ensure compliance with certain consumer reporting laws.
Yea
Passed
29–2
Apr 30, 2025
SB 2225
Relating to the manufacture, distribution, sale, and taxation of ready-to-drink spirit beverages. Against party
Nay
Passed
25–6
Apr 30, 2025
SB 1754
Relating to the authority of a taxing unit to enter into an agreement to exempt from ad valorem taxation a portion of the value of property on which a renewable energy facility is located or is planned to be located.
Nay
Passed
19–12
Apr 30, 2025
SB 506
Relating to requirements for certain ballot propositions and to related procedures and provisions.
Nay
Passed
23–8
Apr 30, 2025
SB 2366
Relating to a grant program to fund certain short line railroad projects.
Yea
Passed
25–6
Apr 30, 2025
SB 324
Relating to requiring state contractors, political subdivisions of this state, and private employers to participate in the federal electronic verification of employment authorization program, or E-verify.
Nay
Passed
19–12
Apr 30, 2025
SB 2308
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Yea
Passed
26–5
Apr 30, 2025
Ask Maddy
·
AI policy assistant
Ask Maddy about Molly Cook
Scope: texas
Hi! I can help you understand Molly Cook's legislative record. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline